SPOK, INC. – Trademark Portfolio
Entity Type: 03
SPOK, INC. holds 77 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 56 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 4 Nice Classification classes. Currently, 45 trademarks are registered and 4 are pending. Notable registered marks include ARCH, GENA, AMCOM, ILAND, and MYALIAS. The owner is based in SPRINGFIELD, VA.
6850 VERSAR CENTER
SPRINGFIELD, VA 22151
Showing of trademarks Trademarks
Trademark Classifications
SPOK, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does SPOK, INC. have?
SPOK, INC. has 77 U.S. trademarks filed with the USPTO. Of these, 45 registered, 4 pending, 7 abandoned, 21 cancelled.
What trademark classes does SPOK, INC. file in?
SPOK, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SPOK, INC.'s most well-known trademarks?
SPOK, INC.'s registered trademark portfolio includes well-known marks such as ARCH, GENA, AMCOM, ILAND, and MYALIAS. These are among 45 currently registered trademarks in the portfolio.
What is SPOK, INC.'s trademark registration success rate?
SPOK, INC. has a 62% trademark registration rate, with 45 out of 73 resolved applications resulting in successful registration. Currently, 4 applications are pending review.